Clinical Trial Update: Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tislelizumab in combination with chemotherapy as perioperative treatment for esophageal squamous cell carcinoma; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Esophagus Cancer | Phase 2 | Status: NOT_YET_RECRUITING